| Policy (N = 17) | Practice (N = 14) | T-test; p-value | ES Cohen | ||||
---|---|---|---|---|---|---|---|---|
 | Rank | M | SD | Rank | M | SD |  | d |
Clinical Perceptions | 1 | 2.69 | 0.63 | 1 | 2.71 | 0.57 | t = 0.11, p = 0.92 | 0.04 |
Staff Development and Support | 2 | 2.57 | 0.35 | 4 | 2.51 | 0.62 | t = 0.74, p = 0.47 | 0.11 |
Consumer Values and Marketing | 3 | 2.55 | 0.55 | 3 | 2.57 | 0.62 | t = 0.11, p = 0.92 | 0.04 |
Impact on Clinical Practice | 4 | 2.43 | 0.60 | 2 | 2.69 | 0.75 | t = 1.02, p = 0.32 | 0.37 |
Consumer Concerns | 5 | 2.42 | 0.56 | 6 | 2.49 | 0.73 | t = 0.32, p = 0.75 | 0.11 |
Research and Outcomes supporting EBP | 6 | 2.30 | 0.44 | 4 | 2.51 | 0.55 | t = 1.20, p = 0.24 | 0.42 |
Agency Compatibility | 7 | 2.24 | 0.54 | 8 | 2.41 | 0.62 | t = 0.80, p = 0.43 | 0.29 |
Beneficial Features (of EBP) | 7 | 2.24 | 0.44 | 14 | 2.24 | 0.80 | t = 0.01, p = 0.99 | 0.00 |
Staffing Resources | 9 | 2.17 | 0.49 | 10 | 2.39 | 0.61 | t = 1.09, p = 0.29 | 0.39 |
System Readiness and Compatibility | 10 | 2.15 | 0.48 | 6 | 2.49 | 0.60 | t = 1.75, p = 0.09 | 0.61 |
Political Dynamics | 11 | 2.10 | 0.74 | 12 | 2.36 | 0.90 | t = 0.88, p = 0.39 | 0.31 |
EBP Limitations | 12 | 2.04 | 0.68 | 11 | 2.38 | 0.74 | t = 1.34, p = 0.19 | 0.47 |
Costs of EBP | 13 | 1.97 | 0.47 | 9 | 2.40 | 0.70 | t = 1.94, p = 0.07 | 0.71 |
Funding | 14 | 1.69 | 0.47 | 13 | 2.26 | 0.97 | t = 2.14, p = 0.04 | 0.75 |